FREMONT, CA, June 10, 2023 — ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company has announced the launch of its new pitch deck, presenting transformative advancements in biopharmaceuticals to potential investors.
ABVC BioPharma’s pitch deck provides an engaging overview of our vision, milestones, and pipeline. It highlights our leadership team, as well as our clinical trial progress and market potential.
Click here to download the 2023 ABVC BioPharma Corporate Overview Presentation.